- Home
- TRUE vs MIST Comparison
TRUE vs MIST Comparison
Compare TRUE & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRUE | MIST |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.6M | 176.3M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | TRUE | MIST |
|---|---|---|
| Price | $2.54 | $2.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $2.55 | ★ $8.50 |
| AVG Volume (30 Days) | 1.6M | ★ 3.6M |
| Earning Date | 02-17-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $181,222,000.00 | N/A |
| Revenue This Year | $9.14 | N/A |
| Revenue Next Year | $7.47 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.18 | N/A |
| 52 Week Low | $1.05 | $0.63 |
| 52 Week High | $3.83 | $3.06 |
Technical Indicators
Market Signals| Indicator | TRUE | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 69.57 | 43.70 |
| Support Level | $2.11 | $1.97 |
| Resistance Level | $2.17 | $2.13 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 100.00 | 31.25 |
Price Performance
Historical ComparisonAbout TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).